Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-20

Clinical Trial Update: Primary Intervention With Mucosal Insulin [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 1/2 study of mucosal insulin used as the primary intervention for Type 1 diabetes mellitus. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mucosal insulin (insulin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Type 1 Diabetes | Phase 1, Phase 2 | Status: COMPLETED